Cardiovascular and cerebrovascular adverse events associated with intravitreal anti-vascular endothelial growth factor monoclonal antibodies: a World Health Organization pharmacovigilance study
- Ophthalmology, July 12, 2024 | https://doi.org/10.1016/j.ophtha.2024.07.008